Pretreatment Features to Influence Effectiveness of Intravesical Hyaluronic Acid Instillation in Refractory Interstitial Cystitis/Painful Bladder Syndrome
Aram Kim, Bumjin Lim, Miho Song, Myung-Soo Choo
Int Neurourol J. 2014;18(3):163-167.   Published online 2014 Sep 24     DOI:
Citations to this article as recorded by Crossref logo
Histopathological characteristics of interstitial cystitis/bladder pain syndrome without Hunner lesion
Aram Kim, Ju-Young Han, Chae-Min Ryu, Hwan Yeul Yu, Seungun Lee, YongHwan Kim, Se Un Jeong, Yong Mee Cho, Dong-Myung Shin, Myung-Soo Choo
Histopathology.2017; 71(3): 415.     CrossRef
Evaluation of the incidence and risk factors associated with persistent frequency in interstitial cystitis/bladder pain syndrome and the efficacy of antimuscarinic treatment
Aram Kim, Kyeong-Ok Hoe, Jung Hyun Shin, Myung-Soo Choo
Investigative and Clinical Urology.2017; 58(5): 353.     CrossRef
Stem Cell Therapy for Interstitial Cystitis/Bladder Pain Syndrome
Aram Kim, Dong-Myung Shin, Myung-Soo Choo
Current Urology Reports.2016;[Epub]     CrossRef
The use of intravesical hyaluronic acid for recurrent urinary tract infections in children: a case-series study
Kibriya Fidan, Bahar Büyükkaragöz, Onur Özen, Billur Demirogullari, Oguz Söylemezoglu
Renal Failure.2015; 37(10): 354.     CrossRef
Interleukin-33 and Mast Cells Bridge Innate and Adaptive Immunity: From the Allergologist’s Perspective
Tae Young Jang, Young Hyo Kim
International Neurourology Journal.2015; 19(3): 142.     CrossRef